Institute for Clinical & Experimental Surgery, Saarland University, Homburg/Saar, Germany.
Institute for Clinical & Experimental Surgery, Saarland University, Homburg/Saar, Germany.
Am J Obstet Gynecol. 2016 Jul;215(1):68.e1-4. doi: 10.1016/j.ajog.2016.02.036. Epub 2016 Feb 18.
Endometriosis is a frequent gynecologic disease with a complex, multifactorial cause. It is characterized by the cyclic estrogen-driven proliferation and bleeding of endometriotic lesions (ie, ectopic endometrial glands and stroma) outside the uterus. These lesions induce a chronic activation of the innate immune system within the peritoneal cavity that is associated with the release of various inflammatory cytokines and angiogenic growth factors into the peritoneal fluid. This stimulates angiogenesis and the further spread of the lesions and triggers the typical pain that is symptomatic of the disease. Moreover, circulating stem and progenitor cells are recruited into the ectopic endometrial tissue and contribute to its growth and vascularization. In recent years, an increasing number of studies have indicated that the gut microbiota is not only essential for a physiologic gastrointestinal function but acts as a central regulator of a variety of inflammatory and proliferative conditions. Besides, the gut flora affects estrogen metabolism and stem-cell homeostasis. Based on these findings, we hypothesize that the gut microbiota may be involved crucially in the onset and progression of endometriosis. In the future, this novel view of the pathogenesis of endometriosis may be verified by analysis of the development of endometriotic lesions in animal models with a defined composition of the gut microbiota and by investigation of the microbiota of patients with endometriosis with modern next-generation sequencing tools. This could open the door for completely new preventive, diagnostic, and therapeutic approaches for endometriosis.
子宫内膜异位症是一种常见的妇科疾病,其病因复杂,涉及多种因素。它的特征是子宫内膜异位病灶(即异位的子宫内膜腺体和基质)在子宫外周期性地受到雌激素驱动而增殖和出血。这些病灶在腹腔内引发固有免疫系统的慢性激活,导致各种炎症细胞因子和血管生成生长因子释放到腹腔液中。这刺激了血管生成和病灶的进一步扩散,并引发了该疾病的典型疼痛症状。此外,循环中的干细胞和祖细胞被招募到异位的子宫内膜组织中,并促进其生长和血管生成。近年来,越来越多的研究表明,肠道微生物群不仅对生理胃肠道功能至关重要,而且还是各种炎症和增殖性疾病的中央调节剂。此外,肠道菌群还会影响雌激素代谢和干细胞的动态平衡。基于这些发现,我们假设肠道微生物群可能在子宫内膜异位症的发病和进展中起着关键作用。未来,通过分析具有特定肠道微生物群组成的动物模型中子宫内膜异位病灶的发展,以及使用现代下一代测序工具研究子宫内膜异位症患者的微生物群,可以验证这种子宫内膜异位症发病机制的新观点。这可能为子宫内膜异位症的预防、诊断和治疗提供全新的方法。